β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis

被引：0
|
作者：
Uta Drebber
Martin Madeja
Margarete Odenthal
Inga Wedemeyer
Stefan P. Mönig
Jan Brabender
Elfriede Bollschweiler
Arnulf H. Hölscher
Paul M. Schneider
Hans P. Dienes
Daniel Vallböhmer
机构：
[1] University Hospital Cologne,Institute of Pathology
[2] University Hospital Cologne,Department of General, Visceral and Cancer Surgery
[3] University Hospital Zurich,Department of Visceral and Transplantation Surgery
来源：
International Journal of Colorectal Disease | 2011年 / 26卷
关键词：
Rectal cancer; Neoadjuvant therapy; Response prediction; Prognosis; β-catenin; Her2/neu;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis
    Drebber, Uta
    Madeja, Martin
    Odenthal, Margarete
    Wedemeyer, Inga
    Moenig, Stefan P.
    Brabender, Jan
    Bollschweiler, Elfriede
    Hoelscher, Arnulf H.
    Schneider, Paul M.
    Dienes, Hans P.
    Vallboehmer, Daniel
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2011, 26 (09) : 1127 - 1134
  • [2] Survivin expression in esophageal cancer: Association with histomorphological response to neoadjuvant therapy and prognosis
    Vallboehmer, D.
    Kuhn, E.
    Brabender, J.
    Metzger, R.
    Warnecke-Eberz, U.
    Baldus, S. E.
    Drebber, U.
    Holscher, A. H.
    Schneider, P. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Survivin expression in gastric cancer: Association with histomorphological response to neoadjuvant therapy and prognosis
    Vallbohmer, Daniel
    Drebber, Uta
    Schneider, Paul M.
    Baldus, Stephan E.
    Bollschweiler, Elfriede
    Brabender, Jan
    Monig, Stefan
    Hoelscher, Arnulf H.
    Metzger, Ralf
    GASTROENTEROLOGY, 2008, 134 (04) : A878 - A878
  • [4] Survivin Expression in Gastric Cancer: Association With Histomorphological Response to Neoadjuvant Therapy and Prognosis
    Vallboehmer, D.
    Drebber, U.
    Schneider, P. M.
    Baldus, S.
    Bollschweiler, E.
    Brabender, J.
    Warnecke-Eberz, U.
    Moenig, S.
    Hoelscher, A. H.
    Metzger, R.
    JOURNAL OF SURGICAL ONCOLOGY, 2009, 99 (07) : 409 - 413
  • [5] Influence of Neoadjuvant Therapy with Epirubicin and Docetaxel on the Expression of HER2/neu in Patients with Breast Cancer
    Susanne Taucher
    Margaretha Rudas
    Robert M. Mader
    Michael Gnant
    Emanuel Sporn
    Peter Dubsky
    Sebastian Roka
    Thomas Bachleitner
    Florian Fitzal
    Daniela Kandioler
    Catharina Wenzel
    Günther G. Steger
    Martina Mittlböck
    Raimund Jakesz
    Breast Cancer Research and Treatment, 2003, 82 : 207 - 213
  • [6] Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer
    Taucher, S
    Rudas, M
    Mader, RM
    Gnant, M
    Sporn, E
    Dubsky, P
    Roka, S
    Bachleitner, T
    Fitzal, F
    Kandioler, D
    Wenzel, C
    Steger, GG
    Mittlböck, M
    Jakesz, R
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 (03) : 207 - 213
  • [7] Association of HER2/neu with complete response in breast carcinoma with neoadjuvant chemotherapy
    Peiró, G
    Adrover, E
    Aranda, FI
    Alenda, C
    Payá, A
    Seguí, J
    LABORATORY INVESTIGATION, 2006, 86 : 38A - 38A
  • [8] Association of HER2/neu with complete response in breast carcinoma with neoadjuvant chemotherapy
    Peiró, G
    Adrover, E
    Aranda, FI
    Alenda, C
    Payá, A
    Seguí, J
    MODERN PATHOLOGY, 2006, 19 : 38A - 38A
  • [9] HER2 as a limited predictor of the therapeutic response to neoadjuvant therapy in locally advanced rectal cancer
    Kwon, Mi Jung
    Soh, Jae Seung
    Lim, Sang-Woo
    Kang, Ho Suk
    Lim, Hyun
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (05) : 910 - 917
  • [10] Her2/neu expression predicts the response to antiaromatase neoadjuvant therapy in primary breast cancer: Subgroup analysis from celecoxib antiaromatase neoadjuvant trial
    Zhu, L
    Chow, LWC
    Loo, WTY
    Guan, XY
    Toi, M
    CLINICAL CANCER RESEARCH, 2004, 10 (14) : 4639 - 4644
12345